PT  - JOURNAL ARTICLE
AU  - Boffetta, Paolo
AU  - Goldfarb, David G.
AU  - Zeig-Owens, Rachel
AU  - Kristjansson, Dana
AU  - Li, Jiehui
AU  - Brackbill, Robert M.
AU  - Farfel, Mark R.
AU  - Cone, James E.
AU  - Yung, Janette
AU  - Kahn, Amy R.
AU  - Qiao, Baozhen
AU  - Schymura, Maria J.
AU  - Webber, Mayris P.
AU  - Prezant, David J.
AU  - Dasaro, Christopher R.
AU  - Todd, Andrew C.
AU  - Hall, Charles B.
TI  - Temporal Aspects of the Association between Exposure to the World Trade Center Disaster and Risk of Skin Melanoma
AID  - 10.1101/2021.03.10.21253261
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.03.10.21253261
4099  - http://medrxiv.org/content/early/2021/03/12/2021.03.10.21253261.short
4100  - http://medrxiv.org/content/early/2021/03/12/2021.03.10.21253261.full
AB  - Rescue/recovery workers who responded to the World Trade Center (WTC) attacks on 9/11/2001 were exposed to known/suspected carcinogens. Studies have identified an increased risk of skin melanoma in this population, but the temporal aspects of the association have not been investigated. A total of 44,540 non-Hispanic White workers from the WTC Combined Rescue/Recovery Cohort were observed between 3/12/2002 and 12/31/2015. Cancer data were obtained via linkages with 13 state registries. Poisson regression was used to estimate hazard ratios (HR) and 95% confidence intervals (CI), using the New York State population as reference; change points in the HRs were estimated using profile likelihood. We observed 247 incident cases of skin melanoma. No increase in incidence was detected between 2002 and 2004. Beginning in 2005, the HR was 1.34 (95% CI 1.18-1.52). A dose-response relationship was observed according to time worked on the WTC effort. Risk of melanoma among non-Hispanic White WTC rescue/recovery workers was elevated, beginning in 2005. While WTC-related exposure to ultraviolet radiation or other agents might have contributed to this result, exposures other than the WTC effort and enhanced medical surveillance cannot be discounted. Our results support the continued surveillance of this population for melanoma.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported through the National Institute for Occupational Safety and Health (NIOSH) cooperative agreements (U01OH011315, U01 OH011932, U01 OH011681, U01 OH011931, U01 OH011480, and U50/OH009739) and contracts (200-2011-39378, 200-2017-93325 and 200-2017-93326). Additionally, this research was supported cooperative agreement 6NU58DP006309 awarded to the New York State Department of Health by the Centers for Disease Control and Prevention (CDC) and by Contract 75N91018D00005 (Task Order 75N91018F00001) from the National Cancer Institute (NCI), National Institutes of Health, Department of Health and Human Services. This research was also supported by cooperative agreement U50/ATU272750 from the Agency for Toxic Substances and Disease Registry (ATSDR), CDC, which included support from the National Center for Environmental Health, CDC; and by the New York City Department of Health and Mental Hygiene (NYC DOHMH). This research was also supported by grant P30 CA013330 from the National Cancer Institute (NCI), NIH.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by Institutional Review Boards at Albert Einstein College of Medicine, New York City Department of Health and Mental Hygiene, the NYS Department of Health, and all thirteen cancer registries. The Icahn School of Medicine at Mount Sinai IRB ruled the research exempt. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData that support the findings of the study may be obtained from the corresponding author (PB) upon reasonable request after approval by the Steering Committee for "Incidence, Latency, and Survival of Cancer Following World Trade Center Exposure" (NIOSH Cooperative Agreement U01 OH011932) in accordance with the study's official Data Sharing Plan.WTC(World Trade Center)FDNY(Fire Department of the City of New York)GRC(General Responder Cohort)WTCHR(World Trade Center Health Registry)NYS(New York State)HR(Hazard Ratio)